JAKARTA – PT Brigit Biofarmaka Teknologi Tbk (OBAT), which recently debuted on the Indonesia Stock Exchange (BEI) on Monday (13/1), has revealed its plan for the use of funds from its IPO.

"We are utilizing the IPO funds entirely for working capital," stated Is Heriyanto, President Director of OBAT, during the Post-IPO Press Conference on Monday (13/1).

How will this working capital be managed to benefit various stakeholders? Stay tuned for the video with more details. (ZH)